outcomes research

Research in Review

Removing Metastases Improves Survival for Patients With Kidney Cancer

04/28/2017

JCP Editors

Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...

...

04/28/2017

Journal of Clinical Pathways

Research in Review

Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse Large B-Cell Lymphoma

04/28/2017

JCP Editors

Lenalidomide maintenance therapy for 24 months after a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large B-cell...

...

04/28/2017

Journal of Clinical Pathways

Research in Review

Serum Marker Helps Predict Response to CAR-T Therapy in Lymphoma

04/28/2017

JCP Editors

Patients with relapsed or refractory lymphoma who achieve durable remission after low-dose conditioning chemotherapy and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tend to have high serum levels of a...

...

04/28/2017

Journal of Clinical Pathways

Research in Review

Risk-Adapted Therapy Recommended for Patients With Hodgkin Lymphoma

04/27/2017

JCP Editors

Long-term follow-up data from multiple studies support the current risk-adapted therapeutic strategies in early-stage Hodgkin lymphoma, according to research published in the Journal of Clinical Oncology (published...

...

04/27/2017

Journal of Clinical Pathways

Research in Review

New Prognostic Marker Identified for Diffuse Large B-Cell Lymphoma

04/27/2017

JCP Editors

A recent meta-analysis identified a strong correlation between an inflammation marker and survival outcomes for patients with diffuse large B-cell lymphoma, published in PLOS One (published online April 25, 2017;...

A...

04/27/2017

Journal of Clinical Pathways

Research in Review

Dose-Escalated Therapy May Be Curative for Multiple B-Cell Malignancies

04/26/2017

JCP Editors

Dose-escalated therapy involving a single agent produced complete and partial responses in patients with different B-cell malignancies. ----- Related Content Maintenance Therapy Effective in Treating Diffuse Large...

...

04/26/2017

Journal of Clinical Pathways

Research in Review

Bone Model Examines Treatment Effectiveness for Breast Cancer Metastases

04/24/2017

JCP Editors

A bone metastasis model has been created that simulates interactions between metastatic breast cancer cells and bone cells to determine effectiveness of different treatments, published in Nature Communications...

A bone...

04/24/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness of Early-Stage Breast Cancer Treatment Options Vary Significantly

04/21/2017

JCP Editors

Certain therapy options for early-stage breast cancer have fewer associated complications and are much less expensive than others, according to a study published in the Journal of the National Cancer Institute...

...

04/21/2017

Journal of Clinical Pathways

Research in Review

Transplantation After High-Dose Chemo Effective in Treating Multiple Myeloma

04/19/2017

JCP Editors

Adult patients with multiple myeloma who receive a high-dose chemotherapy regimen plus autologous stem-cell transplantation improve their median progression-free survival (PFS) by 14 months compared with patients who...

Adult...

04/19/2017

Journal of Clinical Pathways

Research in Review

Maintenance Therapy After Autologous Stem Cell Transplant Improves Survival in MCL

04/18/2017

JCP Editors

Younger patients with mantle cell lymphoma (MCL) who receive an autologous hematopoietic cell transplant after an induction regimen are more likely to prolong their survival with maintenance therapy. ----- Related...

...

04/18/2017

Journal of Clinical Pathways